Continuous Glucose Sensors Help Type 2 Patients Beat Sugar Levels

A new study shows that people with type 2 diabetes who use continuous glucose monitors (CGMs) see better blood‑sugar control than those who stick to finger‑prick tests. The research, published on April 23 in a medical journal, followed over 300 patients for 32 weeks. Half wore CGMs; the others continued traditional testing. In the first 16 weeks, those with CGMs lowered their HbA1c scores—an average blood‑sugar marker—without changing medications. Participants could see real‑time data on a wrist device or phone, which helped them adjust food, activity and insulin use. After 16 weeks, doctors could prescribe new treatments for another 16 weeks. During that second phase, CGM users improved even more.The researchers highlighted that continuous monitoring gives a near‑real‑time view of glucose trends, reducing the risk of low or high spikes that can lead to complications like heart disease or vision loss. While CGMs are standard for type 1 diabetes, they have been less common in type 2 care. This study suggests that many type 2 patients could benefit from the technology. Experts say the findings support wider CGM use, but cost‑effectiveness still needs study. The data show that simple tools can empower patients to manage their condition more safely and with fewer finger‑pricks.